US Drug Market Entry: The FDA Compliance Roadmap Every Pharma, Nutraceutical, Cosmetic, and Biotech Manufacturer Needs

Entering the US market as a foreign pharmaceutical, nutraceutical, cosmetic, or biotech manufacturer is a structured regulatory process requiring careful planning and an understanding of how multiple FDA requirements interact. A compliance misstep early — incorrect facility registration, a non-compliant label, or a missed renewal deadline — can delay or derail US market entry at significant cost. This guide provides the complete FDA compliance roadmap for foreign manufacturers targeting the US market in 2026.

Phase 1: Pre-Entry Planning — Determine Your Regulatory Category

The first decision in US market entry planning is correctly identifying your product's FDA regulatory category. A product sold as a cosmetic in Europe may be regulated as a drug in the US if it makes therapeutic claims or contains active ingredients recognized in OTC drug monographs. Getting classification wrong shapes every subsequent compliance decision.

Phase 2: Acquire Required Identifiers

DUNS Number

All foreign manufacturers registering with the FDA need a DUNS number from Dun & Bradstreet. Required for all FDA facility registrations. Apply early — typically three to five business days for international applicants.

FEI Number and NDC Labeler Code

Drug manufacturers receive an FEI number upon completing facility registration. Drug manufacturers marketing products in the US also need an NDC labeler code — the first segment of the National Drug Code on US drug product labels.

Phase 3: Facility Registration

• Drug facility registration: through FURLS using the Drug Registration and Listing System; renewal every two years October–December

• Food facility registration: through FURLS; renewal every two years; includes US Agent designation

• Cosmetic facility registration under MoCRA: through FDA Cosmetics Direct; annual renewal; requires Responsible Person designation

• Medical device facility registration: through FURLS; annual renewal

For all foreign facilities, US Agent designation is required at the time of registration. The agent must be US-based, available during business hours, and capable of receiving and transmitting FDA communications without delay.

Phase 4: Product Listing

Drug Listing via Structured Product Labeling

Every drug marketed in the US must be listed through the Structured Product Labeling (SPL) system. Drug listing includes the NDC number, established name, dosage form, active and inactive ingredients, and current US-compliant labeling in SPL XML format.

Cosmetic Product Listing Under MoCRA

Every cosmetic marketed in the US must be listed through FDA Cosmetics Direct. Listings require the complete INCI ingredient list and annual renewal.

Phase 5: Labeling Compliance

FDA labeling requirements are product category-specific and highly prescriptive. Build label compliance review into your product development timeline — not your shipping preparation process. Relabeling finished goods is expensive. Relabeling goods in transit to the US is more so.

Phase 6: Import Compliance

For food products, Prior Notice must be filed before every shipment. For all FDA-regulated products, the importing party must demonstrate that the shipment originates from a registered facility, is accurately labeled, and complies with applicable US standards. Import refusals are recorded in FDA's import database and can trigger automatic examination of future shipments.

Phase 7: Ongoing Compliance Management

US market entry is not a one-time event. Maintaining access requires biennial facility registration renewals, annual cosmetic listing renewals, drug listing updates when labeling changes, and responsiveness to FDA inquiries through your US Agent. Foreign manufacturers who treat US compliance as a project with a fixed end date consistently encounter problems.

How Axentra Supports Your US Market Entry

Axentra provides end-to-end US market entry support: regulatory category determination, DUNS and FEI acquisition, facility registration, US Agent designation, product listing, label compliance review, eCTD dossier authoring, and ongoing compliance management. Contact us for a free 24-hour expert assessment.